Literature DB >> 32233924

A method for translational rat ex vivo lung perfusion experimentation.

Akihiro Ohsumi1,2, Takashi Kanou1, Aadil Ali1, Zehong Guan1, David M Hwang1, Thomas K Waddell1, Stephen Juvet1, Mingyao Liu1, Shaf Keshavjee1, Marcelo Cypel1.   

Abstract

The application of ex vivo lung perfusion (EVLP) has significantly increased the successful clinical use of marginal donor lungs. While large animal EVLP models exist to test new strategies to improve organ repair, there is currently no rat EVLP model capable of maintaining long-term lung viability. Here, we describe a new rat EVLP model that addresses this need, while enabling the study of lung injury due to cold ischemic time (CIT). The technique involves perfusing and ventilating male Lewis rat donor lungs for 4 h before transplanting the left lung into a recipient rat and then evaluating lung function 2 h after reperfusion. To test injury within this model, lungs were divided into groups and exposed to different CITs (i.e., 20 min, 6 h, 12 h, 18 h and 24 h). Experiments involving the 24-h-CIT group were prematurely terminated due to the development of severe edema. For the other groups, no differences in the ratio of arterial oxygen partial pressure to fractional inspired oxygen ([Formula: see text]/[Formula: see text]) were observed during EVLP; however, lung compliance decreased over time in the 18-h group (P = 0.012) and the [Formula: see text]/[Formula: see text] of the blood from the left pulmonary vein 2 h after transplantation was lower compared with 20-min-CIT group (P = 0.0062). This new model maintained stable lung function during 4-h EVLP and after transplantation when exposed to up to 12 h of CIT.

Entities:  

Keywords:  ex vivo lung perfusion; ischemia-reperfusion injury; lung transplantation; organ preservation; rat

Year:  2020        PMID: 32233924     DOI: 10.1152/ajplung.00256.2019

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  4 in total

1.  Ex Vivo Lung Perfusion with β-Nicotinamide Adenine Dinucleotide (NAD+) Improves Ischemic Lung Function.

Authors:  Jonas Peter Ehrsam; Jin Chen; Hector Rodriguez Cetina Biefer; Isabelle Opitz; Stephan Arni; Ilhan Inci
Journal:  Antioxidants (Basel)       Date:  2022-04-26

2.  Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion.

Authors:  Roumen Parapanov; Xingyu Wang; Yabo Wang; Anne Debonneville; Jérôme Lugrin; Lucas Liaudet; Thorsten Krueger
Journal:  Transplant Direct       Date:  2022-06-10

3.  A translational rat model for ex vivo lung perfusion of pre-injured lungs after brain death.

Authors:  Judith E van Zanden; Henri G D Leuvenink; Erik A M Verschuuren; Michiel E Erasmus; Maximilia C Hottenrott
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 4.  A Comprehensive Review on the Surgical Aspect of Lung Transplant Models in Mice and Rats.

Authors:  Xin Jin; Janne Kaes; Jan Van Slambrouck; Ilhan Inci; Stephan Arni; Vincent Geudens; Tobias Heigl; Yanina Jansen; Marianne S Carlon; Robin Vos; Dirk Van Raemdonck; Yi Zhang; Bart M Vanaudenaerde; Laurens J Ceulemans
Journal:  Cells       Date:  2022-01-30       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.